The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia.
Open accessAbstract
There is continuing debate about the relative efficacy of low (< 100 mg per day), medium (300 to 325 mg per day), and high (> 900 mg per day) doses of aspirin in patients after a transient ischaemic attack or non-disabling stroke. The purpose of this study was to resolve the issue. Thus a minimeta-analysis was performed on data from 10 randomised trials of aspirin only v control treatment in 6171 patients after a transient ischaemic attack or nondisabling stroke. The data on the trials were listed in an appendix of the report on the second cycle of the Antiplatelet Trialists' Collaboration. There was virtually no difference in relative risk reduction for low, medium, and high doses of aspirin (13%, 9%, and 14% respectively). This equivalence corresponds with the results of the UK-TIA trial in a direct comparison of 300 and 1200 mg. The Dutch TIA trial showed no difference in efficacy of 30 and 283 mg. It is concluded that aspirin at any dose above 30 mg daily prevents 13% (95% confidence interval 4-21) of vascular events and that there is a need for more efficacious drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,592
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Antiplatelet Trialists' Collaboration (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 3,126
Rothman, K. J., Greenland, S., & Lash, T. L. (1998) · Cited by 2,096
Cumulative Meta-Analysis of Therapeutic Trials for Myocardial Infarction
Lau, J., Antman, E. M., Jimenez-Silva, J., Kupelnick, B., Mosteller, F., & Chalmers, T. C. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207233270406 · Cited by 1,140
A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke
The Canadian Cooperative Study Group (1978) · New England Journal of Medicine · doi:10.1056/nejm197807132990201 · Cited by 957
(1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251801 · Cited by 759
Controlled trial of aspirin in cerebral ischemia.
Fields, W. S., Lemak, N. A., Frankowski, R. F., & Hardy, R. J. (1977) · Stroke · doi:10.1161/01.str.8.3.301 · Cited by 631
Bousser, M. G., Eschwege, E., Haguenau, M., Lefaucconnier, J. M., Thibult, N., Touboul, D., & Touboul, P. J. (1983) · Stroke · doi:10.1161/01.str.14.1.5 · Cited by 612
The Salt Collaborative Group (1991) · The Lancet · doi:10.1016/0140-6736(91)92233-r · Cited by 553
Sorensen, P. S., Pedersen, H., Marquardsen, J., Petersson, H., Heltberg, A., Simonsen, N., Munck, O., & Andersen, L. A. (1983) · Stroke · doi:10.1161/01.str.14.1.15 · Cited by 191
Drugs and Surgery in the Prevention of Ischemic Stroke
Barnett, H. J. M., Eliasziw, M., & Meldrum, H. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501263320408 · Cited by 183
High-dose acetylsalicylic acid after cerebral infarction. A Swedish Cooperative Study.
(1987) · Stroke · doi:10.1161/01.str.18.2.325 · Cited by 182
Controlled trial of aspirin in cerebral ischemia. Part II: surgical group.
Fields, W. S., Lemak, N. A., Frankowski, R. F., & Hardy, R. J. (1978) · Stroke · doi:10.1161/01.str.9.4.309 · Cited by 174
Low-dose aspirin and stroke. "It ain't necessarily so".
Dyken, M. L., Barnett, H. J. M., Easton, J. D., et al. (1992) · Stroke · doi:10.1161/01.str.23.10.1395 · Cited by 140
Danish very-low-dose aspirin after carotid endarterectomy trial.
Boysen, G., Sørensen, P. S., Juhler, M., Andersen, A. R., Boas, J., Olsen, J. S., & Joensen, P. (1988) · Stroke · doi:10.1161/01.str.19.10.1211 · Cited by 118
Guiraud-Chaumeil, B., Rascol, A., David, J., et al. (1982) · PubMed · Cited by 58
van Gijn, J., Warlow, C. P., & Norrving, B. G. (1993) · Stroke · doi:10.1161/01.str.24.3.476 · Cited by 47
Cited by
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
(2008) · Cerebrovascular Diseases · doi:10.1159/000131083 · Cited by 2,489
Donnan, G. A., Fisher, M., Macleod, M., & Davis, S. M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60694-7 · Cited by 2,218
European Stroke Initiative Recommendations for Stroke Management – Update 2003
(2003) · Cerebrovascular Diseases · doi:10.1159/000072554 · Cited by 635
Metadata
- Authors
- Algra, A., & van Gijn, J.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 1996-02-01
- Volume
- 60
- Issue
- 2
- Pages
- 197-199
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W2005882777
- Cited by
- 256
- References
- 19
- FWCI
- 9.83
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.